Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 1:44 pm Unchanged | 2022-12-31 | 13G | Disc Medicine, Inc. IRON | SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-10 09:08 am Purchase | 2023-02-09 | 13G | Disc Medicine, Inc. IRON | FMR LLC | 2,142,724 12.661% | 2,142,724 (New Position) | Filing History |
| 2023-01-31 10:07 am Unchanged | 2022-12-31 | 13G | Disc Medicine, Inc. IRON | FRANKLIN RESOURCES INC BEN | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-01-09 4:02 pm Purchase | 2022-12-29 | 13D | Disc Medicine, Inc. IRON | AI DMI LLC | 2,706,976 16.000% | 2,706,976 (New Position) | Filing History |
| 2023-01-09 12:28 pm Purchase | 2022-12-29 | 13G | Disc Medicine, Inc. IRON | BML Investment Partners, L.P. | 524,750 3.100% | 524,750 (New Position) | Filing History |
| 2023-01-04 5:43 pm Purchase | 2022-12-29 | 13D | Disc Medicine, Inc. IRON | FS Development Holdings LLC | 487,025 2.880% | 487,025 (New Position) | Filing History |
| 2023-01-03 5:23 pm Purchase | 2022-12-29 | 13D | Disc Medicine, Inc. IRON | ORBIMED ADVISORS LLC | 2,160,941 12.800% | 2,160,941 (New Position) | Filing History |
| 2023-01-03 4:30 pm Purchase | 2022-12-29 | 13G | Disc Medicine, Inc. IRON | Novo Holdings A/S | 2,340,772 13.800% | 2,340,772 (New Position) | Filing History |
| 2022-10-27 4:30 pm Purchase | 2022-10-25 | 13D | Gemini Therapeutics, Inc. GMTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 350,062 8.090% | 100,062 (+40.02%) | Filing History |
| 2022-10-11 4:31 pm Purchase | 2022-09-28 | 13D | Gemini Therapeutics, Inc. GMTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 250,000 5.780% | 181,739 (+266.24%) | Filing History |
| 2022-08-12 4:46 pm Unchanged | 2022-08-09 | 13D | Gemini Therapeutics, Inc. GMTX | FS Development Holdings LLC | 487,025 11.260% | 0 (Unchanged) | Filing History |
| 2022-04-13 4:11 pm Purchase | 2022-04-11 | 13G | Gemini Therapeutics, Inc. GMTX | BML Investment Partners, L.P. | 527,000 12.200% | 294,030 (+126.21%) | Filing History |
| 2022-03-10 2:01 pm Unchanged | 2022-03-04 | 13G | Gemini Therapeutics, Inc. GMTX | BML Investment Partners, L.P. | 232,970 5.400% | 0 (Unchanged) | Filing History |
| 2022-03-10 1:16 pm Purchase | 2022-03-04 | 13G | Gemini Therapeutics, Inc. GMTX | BML Investment Partners, L.P. | 232,970 5.400% | 232,970 (New Position) | Filing History |
| 2022-02-14 4:54 pm Sale | 2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX | Alyeska Investment Group, L.P. | 0 0.000% | -84,605 (Position Closed) | Filing History |
| 2022-02-11 4:47 pm Purchase | 2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX | SUVRETTA CAPITAL MANAGEMENT, LLC | 237,227 5.500% | 13,942 (+6.24%) | Filing History |
| 2022-02-10 08:45 am Purchase | 2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 68,261 1.580% | 68,261 (New Position) | Filing History |
| 2022-02-04 09:26 am Sale | 2021-12-31 | 13G | FS DEV CORP COM FSDC | Wellington Management Group LLP | 0 0.000% | -990,000 (Position Closed) | Filing History |
| 2022-02-04 08:01 am Unchanged | 2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX | Hawkes Bay Master Investors (Cayman) L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-03 2:36 pm Purchase | 2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX | FRANKLIN RESOURCES INC BEN | 251,277 5.800% | 251,277 (New Position) | Filing History |